About
Lipoprotein Delivery, Small Molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalNJ, NY, PA
Team (6)
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
878
By Phase
PHASE3: 4PHASE2: 7PHASE1/PHASE2: 1
By Status
COMPLETED: 7RECRUITING: 2TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06470451Lead Sponsor
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
PHASE3Recruiting
80 participants
Started: Jan 7, 2025 · Completed: Oct 31, 2026
NCT06386744Lead Sponsor
Dusquetide for the Treatment of Behcet's Disease
PHASE2Completed
8 participants
Started: Nov 18, 2024 · Completed: Jun 17, 2025
NCT06149247Lead Sponsor
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
PHASE2Completed
10 participants
Started: Dec 5, 2023 · Completed: Jun 27, 2024
NCT05872854Collaborator
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
PHASE2Active, not recruiting
20 participants
Started: Aug 21, 2023 · Completed: Dec 15, 2025
NCT05442190Lead Sponsor
Topical SGX302 for Mild-to-Moderate Psoriasis
PHASE2Recruiting
47 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...